Manjula Maganti

Papers

Total Citations

224

H-Index

About

Manjula Maganti is a leading researcher in gynecologic oncology, with a primary focus on improving surgical staging and treatment outcomes for endometrial cancer. Her most cited work, the 2020 study “Assessment of Sentinel Lymph Node Biopsy vs Lymphadenectomy for Intermediate- and High-Grade Endometrial Cancer Staging,” has garnered over 224 citations, underscoring its impact on clinical practice. This landmark investigation addressed a critical question: whether sentinel lymph node biopsy (SLNB) using indocyanine green can safely replace traditional lymphadenectomy for surgical staging in patients with high-grade endometrial cancer. By rigorously examining diagnostic accuracy, performance characteristics, and associated morbidity, Maganti provided compelling evidence that SLNB offers a less invasive alternative without compromising staging precision. Her contributions have helped shift paradigms in surgical management, reducing patient morbidity while maintaining oncologic safety. Beyond this pivotal study, Maganti’s work continues to influence guidelines and clinical decision-making, making her a respected voice in the field. For students and researchers, her research exemplifies how methodologically sound studies can directly translate into improved patient care, highlighting the power of evidence-based innovation in gynecologic oncology.